Compare PCRX & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCRX | CCNE |
|---|---|---|
| Founded | 2006 | 1865 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2010 | 1995 |
| Metric | PCRX | CCNE |
|---|---|---|
| Price | $25.20 | $34.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $30.25 | ★ $34.50 |
| AVG Volume (30 Days) | ★ 441.8K | 110.5K |
| Earning Date | 04-30-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 2.51% |
| EPS Growth | ★ 107.44 | 4.18 |
| EPS | 0.19 | ★ 1.79 |
| Revenue | ★ $541,533,000.00 | N/A |
| Revenue This Year | $6.78 | $23.21 |
| Revenue Next Year | $8.54 | $7.00 |
| P/E Ratio | $134.53 | ★ $18.94 |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $22.90 |
| 52 Week High | $27.66 | $36.17 |
| Indicator | PCRX | CCNE |
|---|---|---|
| Relative Strength Index (RSI) | 50.55 | 50.19 |
| Support Level | $24.61 | $34.07 |
| Resistance Level | $25.17 | $35.17 |
| Average True Range (ATR) | 0.84 | 0.65 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 53.99 | 43.41 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
CNB Financial Corp is a Pennsylvania-chartered bank. The bank is a full-service bank engaging in a full range of banking activities and services for individual, business, governmental and institutional customers. These activities and services principally include checking, savings, and time deposit accounts; real estate, commercial, industrial, residential and consumer loans; and a variety of other specialized financial services. Its Private Client Solutions division offers a full range of client services, including private banking and wealth and asset management. The banking segment derives its revenue through the operations as a full-service bank services, including trust and wealth management services, for individual, business, governmental, and institutional customers.